摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-bromo-4-(dimethoxymethyl)-2-((1-isopropylpiperidin-4-yl)methoxy)pyridine | 939774-08-0

中文名称
——
中文别名
——
英文名称
5-bromo-4-(dimethoxymethyl)-2-((1-isopropylpiperidin-4-yl)methoxy)pyridine
英文别名
——
5-bromo-4-(dimethoxymethyl)-2-((1-isopropylpiperidin-4-yl)methoxy)pyridine化学式
CAS
939774-08-0
化学式
C17H27BrN2O3
mdl
——
分子量
387.317
InChiKey
JGPQQSJZCFLJGK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.63
  • 重原子数:
    23.0
  • 可旋转键数:
    7.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    43.82
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    5-bromo-4-(dimethoxymethyl)-2-((1-isopropylpiperidin-4-yl)methoxy)pyridine盐酸 、 sodium tetrahydroborate 、 正丁基锂 作用下, 以 四氢呋喃甲醇乙醇 为溶剂, 反应 21.0h, 生成 4-(3,4-dichloro-phenyl)-7-(1-isopropyl-piperidin-4-ylmethoxy)-2-methyl-1,2,3,4-tetrahydro-[2,6]naphthyridine
    参考文献:
    名称:
    Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors
    摘要:
    A series of novel tetrahydronaphthyridine-based histamine H-3 ligands that have serotonin reuptake transporter inhibitor activity is described. The 1,2,3,4-tetrahydro-2,6-naphthyridine scaffold is assembled via the addition of a nitrostyrene to a metalated pyridine followed by reduction and cyclization to form the naphthyridine. In vitro biological data for these novel compounds are discussed. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.02.006
  • 作为产物:
    描述:
    参考文献:
    名称:
    Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors
    摘要:
    A series of novel tetrahydronaphthyridine-based histamine H-3 ligands that have serotonin reuptake transporter inhibitor activity is described. The 1,2,3,4-tetrahydro-2,6-naphthyridine scaffold is assembled via the addition of a nitrostyrene to a metalated pyridine followed by reduction and cyclization to form the naphthyridine. In vitro biological data for these novel compounds are discussed. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.02.006
点击查看最新优质反应信息